Bioavailability of Insulin Administered in Duodenum

• Status: Completed
• Trial end date: 2006-12-01
• Target enrollment: 0
• Participant gender: All

Summary

A study of the bioavailability of insulin after infusion in the duodenum in healthy volunteers.

• Phase: Phase 1/Phase 2
• Accepts Healthy Volunteers?: Accepts Healthy Volunteers

Details

• Lead Sponsor: University of Aarhus
• Collaborator: Aarhus University Hospital
• Treatments: Insulin; Insulin Aspart; Insulin, Globin Zinc

Criteria

Inclusion Criteria:

• Signed informed consent

• Healthy Volunteers

• Age >18 - < 50 years

• BMI 18-30 kg/m2

Exclusion Criteria:

• Any history of gastrointestinal or endocrine disorders (e.g. diabetes mellitus)

• pregnancy or nursing

• suspected or known allergy towards the drug

• Participation in other research trials within 3 months before the study